diarrhea
caus
bacteri
viral
parasit
pathogen
europ
north
america
industri
countri
vast
major
episod
diarrhea
caus
viral
pathogen
exhibit
distinct
winter
season
develop
countri
poor
hygien
sanit
enter
bacteria
parasit
prev
iarrheal
diseas
among
lead
caus
death
among
children
develop
countri
claim
estim
million
live
year
industri
countri
although
death
diarrhea
uncommon
occurr
diseas
remain
import
caus
morbid
incur
substanti
health
care
cost
addit
direct
health
burden
consequ
diarrhea
includ
malnutrit
diminish
growth
impair
cognit
develop
recent
year
advanc
diagnost
led
identif
new
caus
agent
improv
understand
etiolog
role
previous
recogn
pathogen
guidelin
manag
diarrhea
refin
new
strategi
prevent
control
identifi
articl
review
current
knowledg
epidemiolog
featur
caus
agent
pathogen
mechan
clinic
manifest
manag
strategi
prevent
control
acut
infecti
diarrhea
young
children
basi
clinic
epidemiolog
paramet
episod
diarrhea
classifi
three
categori
acut
diarrhea
dysenteri
persist
diarrhea
acut
diarrhea
defin
presenc
three
loos
wateri
stool
within
period
dysenteri
often
term
bloodi
diarrhea
indic
presenc
visibl
blood
mucou
diarrheal
stool
episod
diarrhea
last
day
refer
persist
diarrhea
develop
countri
death
caus
diarrhea
declin
incid
consist
past
decad
tabl
estim
million
death
approxim
million
death
year
declin
mortal
rate
attribut
sever
factor
widespread
distribut
use
oral
rehydr
solut
or
improv
rate
breastfeed
improv
nutrit
better
sanit
hygien
increas
coverag
measl
immun
although
ascertain
individu
impact
factor
difficult
strike
invers
associ
coverag
rate
or
rate
mortal
diarrhea
variou
countri
provid
strong
argument
signific
contribut
intervent
fig
although
rate
mortal
diarrhea
declin
substanti
morbid
diarrhea
remain
rel
constant
past
two
decad
child
year
age
experienc
averag
three
episod
rang
annual
wherea
intervent
diarrheal
diseas
breastfeed
improv
sanit
would
expect
affect
mortal
morbid
simultan
increas
use
or
improv
nutrit
statu
like
greater
impact
rate
mortal
diarrhea
may
explain
rel
lack
declin
incid
diarrhea
incid
risk
mortal
diarrheal
diseas
greatest
among
children
younger
year
age
thereaft
rate
declin
increment
alent
agent
typic
peak
summer
month
evid
suggest
rate
diarrheal
mortal
declin
develop
countri
viral
agent
assum
increasingli
import
etiolog
role
exampl
assess
death
diarrhea
mexican
children
show
death
rate
peak
summer
month
bacteri
agent
preval
howev
mortal
rate
declin
peak
mortal
rate
shift
toward
winter
month
enter
virus
particularli
rotaviru
preval
differ
epidemiolog
pattern
bacteri
viral
agent
diarrhea
provid
clue
mode
transmiss
implic
prevent
diseas
bacteri
pathogen
preval
develop
countri
fecalor
spread
often
facilit
condit
poor
hygien
sanit
thought
import
mode
transmiss
viral
pathogen
also
transmit
rout
howev
fact
certain
agent
rotaviru
infect
nearli
children
develop
industri
countri
time
reach
age
year
suggest
transmiss
may
occur
mechan
fomit
respiratori
secret
also
impli
rate
diarrheal
mortal
declin
viral
agent
becom
promin
tradit
measur
use
improv
hygien
sanit
may
reduc
incid
diseas
significantli
strategi
vaccin
prevent
ill
like
effect
next
section
discuss
briefli
epidemiolog
featur
common
bacteri
viral
parasit
caus
diarrhea
children
develop
countri
children
develop
countri
expos
wide
rang
bacteri
enter
pathogen
earli
age
suffer
numer
episod
diarrheal
ill
result
predomin
bacteri
pathogen
vari
age
child
also
time
show
season
secular
trend
well
geograph
variat
experi
individu
child
uniqu
diarrheagen
escherichia
coli
shigella
spp
campylobact
spp
vibrio
spp
salmonella
among
commonli
recogn
bacteri
caus
diarrhea
among
young
children
publish
summari
studi
children
sought
care
diarrhea
countri
rotaviru
enteropathogen
frequent
etec
strain
frequent
caus
acut
secretori
diarrhea
among
children
develop
countri
also
major
caus
travel
diarrhea
epec
strain
caus
acut
secretori
diarrhea
predominantli
children
year
age
younger
especi
month
younger
epec
strain
associ
chronic
diarrhea
children
rare
caus
diseas
adult
eiec
strain
caus
bloodi
mucoid
diarrhea
share
mani
biochem
pathogen
properti
shigella
organ
wateri
diarrhea
also
seen
fever
common
find
ehec
strain
also
caus
bloodi
diarrhea
sever
hemorrhag
coliti
hemolyt
urem
syndrom
seen
mani
percent
infect
ehec
infect
common
occurr
develop
countri
although
larg
outbreak
describ
swaziland
unit
state
countri
cattl
predomin
reservoir
ehec
eaggec
recogn
increasingli
import
diarrheal
pathogen
although
mechan
act
remain
poorli
understood
associ
wateri
diarrhea
young
children
report
caus
persist
diarrhea
children
adult
human
immunodefici
viru
hiv
campylobact
one
frequent
isol
bacteria
stool
infant
children
develop
countri
associ
wateri
diarrhea
occas
dysenteri
peak
isol
rate
found
children
year
age
younger
syndrom
autoimmun
disord
peripher
nervou
system
lead
complet
paralysi
rare
complic
infect
campylobact
poultri
import
sourc
campylobact
infect
develop
countri
presenc
anim
cook
area
risk
factor
acquir
campylobacteriosi
develop
countri
shigella
estim
caus
million
infect
annual
develop
countri
primarili
children
shigella
infect
rel
common
find
toddler
older
children
infant
four
recogn
subgroup
shigella
shigella
sonnei
shigella
flexneri
shigella
boydii
shigella
dysenteria
multipl
serotyp
within
subgroup
except
sonnei
sonnei
subgroup
caus
mildest
ill
seen
commonli
develop
countri
flexneri
like
caus
dysenter
symptom
persist
ill
common
subgroup
develop
countri
sonnei
next
common
two
subgroup
compris
less
percent
isol
studi
noteworthi
associ
sever
diseas
particular
dysenteria
type
produc
shigatoxin
ehec
caus
devast
epidem
bloodi
diarrhea
report
casefat
rate
approach
percent
asia
africa
central
america
mani
speci
vibrio
caus
diarrhea
develop
countri
caus
epidem
cholera
v
cholera
serogroup
special
import
ill
produc
deplet
volum
rapidli
sever
cholera
absenc
prompt
adequ
rehydr
hypovolem
shock
death
occur
within
hour
onset
first
symptom
stool
wateri
colorless
fleck
mucu
vomit
common
find
fever
rare
event
lifethreaten
electrolyt
imbal
must
avoid
use
appropri
solut
rehydr
children
cholera
especi
prone
develop
hypoglycemia
lead
convuls
death
potenti
epidem
spread
confirm
suspect
case
cholera
includ
sever
dehydr
diarrheal
ill
patient
year
report
promptli
public
health
author
serotyp
salmonella
exist
pathogen
human
infant
elderli
appear
greatest
risk
age
group
suscept
salmonellosi
anim
major
reservoir
salmonella
differ
serotyp
predomin
among
reptil
fowl
mammal
acut
onset
nausea
vomit
diarrhea
may
wateri
less
frequent
dysenter
character
case
salmonella
gastroenter
fever
occur
approxim
percent
affect
children
bacteremia
occur
percent
patient
frequent
infant
enter
fever
classic
associ
salmonella
serotyp
typhi
typhoid
fever
serotyp
paratyphi
b
c
also
seen
rare
nontyphi
serotyp
typhoid
fever
identifi
frequent
among
schoolag
children
also
present
milder
form
children
year
age
younger
children
diseas
uncommonli
present
diarrhea
without
blood
character
fever
last
week
complic
typhoid
fever
includ
intestin
hemorrhag
perfor
myocard
mening
pneumonia
shock
rotaviru
rotaviru
lead
caus
sever
dehydr
gastroenter
among
children
account
onethird
hospit
diarrhea
estim
death
worldwid
year
nearli
children
industri
develop
countri
infect
rotaviru
time
year
age
neonat
infect
common
occurr
often
asymptomat
incid
clinic
ill
peak
children
month
age
rotaviru
associ
gastroenter
aboveaverag
sever
thu
proport
episod
diarrhea
attribut
rotaviru
increas
increas
sever
ill
percent
diarrhea
episod
commun
percent
episod
requir
outpati
therapi
percent
episod
requir
hospit
children
often
infect
rotaviru
multipl
time
infect
confer
progress
greater
immun
therefor
sever
diseas
occur
commonli
young
children
first
second
infect
rotavirus
classifi
differ
strain
g
p
type
basi
two
outer
capsid
protein
theoret
differ
strain
rotaviru
could
result
variou
combin
known
g
p
type
human
rotavirus
howev
four
common
strain
rotaviru
p
p
p
p
preval
global
compar
counterpart
industri
countri
children
develop
countri
experi
first
sever
infect
rotaviru
younger
age
exhibit
yearround
rather
season
diseas
like
infect
unusu
multipl
strain
rotaviru
human
calicivirus
hucv
hucv
group
nonenvelop
small
round
virus
belong
two
genera
famili
calicivirida
norovirus
sapovirus
previous
call
norwalklik
virus
sapporolik
virus
respect
infect
prototyp
strain
norwalk
viru
recogn
nearli
two
decad
ago
common
occurr
children
etiolog
role
hucv
could
assess
accur
lack
simpl
sensit
diagnost
assay
clone
sequenc
genom
norwalk
sever
hucv
allow
develop
polymeras
chain
reactionbas
assay
detect
viru
stool
enzym
immunoassay
detect
serolog
respons
assay
show
norovirus
common
caus
outbreak
gastroenter
affect
age
group
wherea
sapovirus
affect
primarili
children
etiolog
role
norovirus
moderatetosever
childhood
gastroenter
develop
countri
studi
preliminari
data
industri
countri
indic
may
second
common
viral
agent
rotaviru
account
percent
episod
sever
gastroenter
young
children
viral
agent
enter
adenovirus
serotyp
astrovirus
associ
approxim
percent
episod
gastroenter
young
children
sever
enter
virus
includ
coronavirus
torovirus
enterovirus
detect
children
diarrhea
etiolog
role
poorli
defin
bacteri
viral
agent
respons
major
infecti
diarrheal
ill
among
children
develop
countri
parasit
agent
account
rel
small
proport
case
giardia
lamblia
cryptosporidium
parvum
entamoeba
histolytica
cyclospora
cayetanenesi
parasit
commonli
caus
acut
diarrheal
ill
children
preval
g
lamblia
low
approxim
among
children
develop
countri
high
percent
develop
region
although
often
asymptomat
infect
giardia
organ
lead
signific
anorexia
growth
impair
small
proport
case
infect
cryptosporidium
cyclospora
organ
common
occurr
among
children
develop
countri
frequent
asymptomat
exampl
recent
studi
peru
show
children
younger
year
age
averag
episod
cyclosporiasi
annual
episod
cryptosporidiosi
annual
twothird
infect
caus
agent
asymptomat
proport
case
result
clinic
ill
declin
increas
age
develop
world
diarrheal
infect
parasit
origin
uncommon
occurr
usual
restrict
person
recent
travel
region
pathogen
endem
howev
vigil
surveil
waterborn
diseas
advent
sever
recent
outbreak
cryptosporiodosi
cyclosporiasi
unit
state
develop
region
bring
attent
increas
import
parasit
human
enteropathogen
worldwid
inoculum
requir
caus
diseas
vari
substanti
differ
enter
pathogen
pathogen
salmonella
approxim
organ
must
ingest
caus
ill
hand
shigella
entamoeba
giardia
spp
norwalk
viru
ingest
organ
caus
ill
express
certain
blood
group
antigen
host
influenc
suscept
infect
organ
v
cholera
norovirus
children
decreas
gastric
acid
may
result
chronic
asymptomat
infect
helicobact
pylori
caus
higher
risk
develop
infect
bacteri
pathogen
enter
bacteria
produc
clinic
diseas
two
primari
mechan
product
toxin
invas
enter
mucosa
varieti
toxin
produc
enter
pathogen
agent
v
cholera
etec
produc
enterotoxin
caus
diarrhea
activ
secretori
mechan
intestin
mucosa
etec
produc
heatstabl
sta
stb
heatlabil
lt
lt
ii
toxin
heatlabil
toxin
etec
close
resembl
cholera
toxin
other
dysenteria
vibrio
parahemolyticu
produc
cytotoxin
lead
destruct
intestin
epithelium
result
inflammatori
diarrhea
final
agent
staphylococcu
aureu
bacillu
cereu
induc
neurotoxin
induc
diarrhea
act
directli
nervou
system
dysenteri
result
either
product
cytotoxin
direct
invas
intestin
mucosa
pathogen
shigella
organ
eiec
enter
pathogen
salmonella
typhi
yersinia
enterocolitica
penetr
intestin
mucosa
dissemin
region
lymphat
enter
bloodstream
result
system
manifest
enter
virus
caus
diarrhea
multipl
mechan
includ
interf
gastrointestin
motil
destroy
intestin
epithelium
reduc
brush
border
enzym
lack
enzym
result
failur
metabol
dietari
carbohydr
consequ
produc
osmot
diarrhea
studi
mice
indic
nonstructur
protein
rotaviru
act
enterotoxin
caus
secretori
diarrhea
alter
epitheli
cell
function
permeabl
addit
rotaviru
may
evok
fluid
secret
activ
enter
nervou
system
intestin
wall
recent
data
indic
rotaviru
antigen
rna
present
serum
children
acut
rotaviru
infect
suggest
rotaviru
possibl
escap
intestin
tract
children
result
antigeniemia
possibl
viremia
investig
need
establish
import
find
understand
pathogenesi
rotaviru
relat
extraintestin
spread
sever
diseas
acut
diarrhea
usual
manifest
increas
frequenc
volum
stool
fever
common
occurr
usual
associ
invas
pathogen
bloodi
stool
present
diarrhea
caus
invas
pathogen
releas
cytotoxin
presenc
bloodi
stool
absenc
fecal
leukocyt
rais
consider
ehec
infect
viral
agent
bacteria
releas
enterotoxin
usual
caus
bloodi
diarrhea
vomit
observ
frequent
viral
diarrhea
ill
caus
ingest
preform
bacteri
toxin
eg
aureu
despit
clue
determin
caus
agent
diarrhea
individu
patient
base
clinic
ground
alon
usual
difficult
synergist
relationship
malnutrit
diarrhea
well
recogn
approxim
percent
children
develop
countri
sever
underweight
percent
suffer
wast
stunt
respect
diarrhea
prolong
durat
sever
children
macronutri
micronutri
defici
persist
diarrhea
often
result
malabsorpt
signific
weight
loss
promot
cycl
children
poor
nutrit
statu
measur
anthropometr
growth
also
elev
risk
diarrheal
death
zinc
defici
particular
suppress
immun
system
function
associ
increas
preval
persist
diarrhea
similarli
children
immunosuppress
secondari
infect
hiv
chronic
condit
may
increas
risk
develop
clinic
ill
prolong
resolut
symptom
frequent
recurr
diarrheal
episod
effect
prevent
mortal
manag
morbid
associ
diarrheal
ill
among
children
depend
make
time
accur
assess
statu
hydrat
follow
promptli
institut
appropri
treatment
children
present
acut
diarrhea
evalu
promptli
featur
dehydr
ascertain
inform
sever
ill
need
rapid
initi
therapi
current
world
health
organ
integr
manag
childhood
ill
guidelin
assess
dehydr
present
tabl
addit
practic
guidelin
treatment
acut
gastrointestin
ill
children
also
avail
american
academi
pediatr
diarrheaassoci
dehydr
isonatrem
measur
serum
electrolyt
usual
requir
children
either
moder
dehydr
atyp
clinic
histori
find
children
sever
dehydr
featur
hypernatrem
dehydr
irrit
doughi
feel
skin
sought
specif
condit
requir
specif
rehydr
method
stool
cultur
usual
indic
case
dysenteri
determin
etiolog
outbreak
monitor
antimicrobi
resist
bacteri
pathogen
sever
dehydr
medic
emerg
intraven
rehydr
therapi
institut
immedi
lactat
ringer
solut
normal
salin
similar
solut
administ
rate
mlkg
bodi
weight
puls
perfus
mental
statu
return
normal
instanc
larg
dose
may
need
administ
rapidli
might
requir
use
multipl
intraven
line
case
altern
rout
administr
intraoss
infus
electrolyt
level
assess
although
therapi
begun
safe
absenc
data
soon
child
condit
stabl
mental
statu
normal
therapi
chang
oral
rout
describ
children
mild
moder
dehydr
oral
rehydr
therapi
ort
initi
or
administ
rate
mlkg
bodi
weight
per
hour
period
hour
fig
or
contain
mixtur
glucos
sodium
potassium
chlorid
bicarbon
base
optim
osmolar
or
determin
concentr
sodium
glucos
reevalu
recent
unit
nation
children
fund
unicef
recent
revis
guidelin
suggest
use
orss
hyposmot
solut
previous
promot
sever
clinic
trial
document
clear
advantag
result
metaanalysi
conclud
children
treat
or
lower
osmolar
measur
reduct
stool
output
vomit
less
need
intraven
rehydr
compar
children
treat
standard
or
new
or
contain
gl
glucos
mmoll
sodium
mmoll
potassium
mmoll
chlorid
mmoll
base
bicarbon
solut
total
osmolar
mosml
addit
or
sever
commerci
solut
avail
appropri
rehydr
loss
caus
diarrheal
ill
children
unabl
toler
or
oral
rout
nasogastr
ng
feed
use
administ
or
ng
feed
particularli
benefici
patient
persist
vomit
oral
administr
first
hour
rehydr
therapi
given
fluid
balanc
maintain
continu
administr
or
ageappropri
intak
nutrient
includ
breastfeed
infant
nutrientdens
solid
food
intak
children
maintain
concern
patient
lactos
intoler
immedi
diarrheal
episod
appear
larg
unfound
special
formula
dilut
gener
unnecessari
import
suffici
calor
intak
emphas
offset
weight
loss
ill
fundament
facilit
proper
growth
develop
effort
made
educ
mother
caregiv
earli
recognit
dehydr
appropri
or
therapi
energi
intak
exclus
breastfeed
recommend
infant
younger
month
old
identif
local
avail
food
support
nutrient
calor
need
older
children
may
use
antimicrobi
agent
usual
recommend
routin
treatment
acut
diarrheal
ill
episod
caus
bacteria
parasit
selflimit
manag
effect
or
adequ
food
intak
inappropri
use
antimicrobi
promot
antimicrobi
resist
treatment
antimicrobi
recommend
campylobact
infect
immunocompromis
person
extraintestin
infect
erythromycin
azithromycin
dihydr
agent
commonli
use
treatment
campylobact
infect
increas
resist
macrolid
fluoroquinolon
agent
note
mani
countri
antimicrobi
treatment
also
decreas
durat
ill
cholera
fluid
requir
durat
excret
v
cholera
may
use
sever
case
adjunct
rehydr
therapi
trimthoprimsulfamethoxazol
may
use
treat
younger
children
wherea
doxycyclin
tetracyclin
use
often
older
children
adult
treatment
antimicrobi
agent
limit
durat
sever
shigellosi
recommend
ill
character
bloodi
stool
high
fever
howev
shigella
organ
rapidli
acquir
resist
varieti
antimicrobi
agent
strain
resist
commonli
use
antimicrobi
agent
includ
fluoroquinolon
recent
report
bangladesh
india
rais
specter
potenti
untreat
infect
appropri
treatment
shigella
spp
includ
limit
nalidix
acid
ciprofloxacin
pivmecillinam
extens
list
publish
elsewher
specif
antimicrobi
empir
treatment
base
assess
sunken
eye
done
object
ask
mother
caregiv
familiar
child
pinch
longitudin
eg
thoracoinguin
direct
thumb
forefing
held
second
releas
open
finger
thumb
region
endem
resist
pattern
avail
shigella
spp
antimicrobi
treatment
nontyphi
salmonellosi
reserv
extraintestin
infect
specif
antimicrobi
therapi
ampicillin
chloramphenicol
trimethoprimsulfamethoxazol
indic
shorten
durat
symptom
lower
risk
develop
complic
children
ill
caus
typhi
oral
nitazoxanid
recommend
treatment
diarrheal
ill
associ
g
lamblia
c
parvum
trimethoprimsulfamethoxazol
effect
treat
cyclosporiasi
random
trial
shown
probiot
lactobacillu
gg
nativ
compon
human
intestin
flora
hasten
recoveri
diarrheal
episod
reduc
risk
recurr
infect
benefit
gener
thought
associ
abil
probiot
stimul
host
humor
immun
defens
adjunct
treatment
lactobacillu
casei
gg
enhanc
local
rotavirusspecif
iga
respons
howev
adequ
data
avail
recommend
routin
use
probiot
treatment
diarrhea
children
varieti
nonspecif
antidiarrhea
agent
eg
kaolin
antimotil
agent
eg
loperamid
antisecretori
agent
eg
bismuth
salicyl
toxin
adsorb
eg
cholestyramin
use
treatment
diarrhea
older
children
adult
safeti
efficaci
agent
establish
children
current
recommend
treatment
supplement
zinc
shown
efficaci
adjunct
therapi
acut
persist
diarrheal
episod
children
develop
countri
result
recent
metaanalysi
review
seven
trial
acut
diarrhea
conclud
treatment
zinc
shorten
durat
lessen
sever
ill
administr
zinc
supplement
children
suffer
persist
diarrhea
recommend
random
trial
demonstr
util
reduc
mortal
rate
percent
rang
percent
among
children
persist
diarrheal
ill
research
need
tabl
assess
dehydr
given
infant
even
acut
rehydr
otherwis
food
given
acut
rehydr
phase
initi
soon
possibl
fluid
level
restor
children
still
nurs
month
older
given
supplement
food
addit
breastmilk
energi
micronutrientrich
food
grain
meat
fruit
veget
recommend
children
tri
eat
frequent
small
meal
throughout
day
mealsday
energi
intak
continu
increas
toler
follow
diarrheal
episod
allow
catchup
growth
continu
develop
sourc
world
health
organ
treatment
diarrhoea
manual
physician
senior
health
worker
geneva
world
health
organ
determin
mechan
action
zinc
identifi
method
optim
deliveri
research
vitamin
supplement
less
consist
gener
support
use
vitamin
supplement
reduc
morbid
associ
acut
diarrhea
recent
estim
attribut
million
death
diseas
relat
water
sanit
hygien
infecti
diarrhea
primari
caus
moreov
percent
diseas
burden
occur
among
children
younger
year
age
diseas
burden
almost
entir
prevent
measur
well
understood
wide
implement
industri
countri
centuri
yet
onefifth
world
popul
lack
access
potabl
water
nearli
onehalf
lack
access
adequ
sanit
millenium
develop
goal
seek
reduc
proport
percent
howev
earlier
global
effort
includ
water
sanit
decad
fell
far
short
achiev
even
level
success
tradit
approach
provis
safe
drink
water
dispos
infecti
human
wast
reli
larg
infrastructur
project
eg
pipe
treatment
system
costli
timeconsum
laborintens
build
maintain
remain
essenti
longterm
object
approach
base
combin
distribut
technolog
behavior
chang
commun
pointofus
water
treatment
offer
immedi
mean
acceler
health
gain
associ
improv
water
one
model
implement
safe
water
system
program
promot
dozen
countri
us
center
diseas
control
prevent
cdc
median
reduct
incid
diarrheal
diseas
result
improv
sanit
estim
percent
high
percent
select
studi
met
rigor
scientif
criteria
convinc
peopl
pay
regularli
use
improv
sanit
facil
challeng
communitybas
schoolbas
approach
achiev
notabl
success
impress
concurr
reduct
evid
diarrheal
diseas
ecolog
sanit
reli
compost
latrin
dehydr
latrin
urin
separ
enabl
recoveri
nutrient
wast
matter
agricultur
use
minim
water
pollut
studi
activ
econom
environment
friendli
altern
tradit
latrin
sewerag
housefli
transfer
bacteri
pathogen
shigella
organ
fece
infect
individu
hand
food
suscept
one
therebi
serv
vector
transmiss
diarrheal
diseas
improv
sanit
diminish
opportun
fli
contact
human
excreta
object
also
attain
diminish
fli
densiti
insecticid
spray
fli
trap
three
welldesign
studi
demonstr
reduct
incid
diarrhea
rang
percent
shigellosi
intervent
control
fli
implement
hygien
sanit
poor
potenti
proper
hygien
prevent
transmiss
diarrheal
diseas
high
abund
environment
contamin
human
anim
wast
recent
metaanalysi
studi
conclud
promot
handwash
intervent
reduc
risk
diarrhea
percent
sever
intestin
infect
percent
wash
soap
enhanc
remov
pathogen
hand
may
provid
pleasant
sensori
associ
lead
frequent
complianc
handwash
recommend
waterless
hand
sanit
gel
alcoholbas
hand
sanit
wide
use
hospit
eventu
may
use
develop
countri
water
scarc
made
avail
low
cost
handwash
critic
timesaft
defec
clean
infant
young
child
defec
prepar
food
eat
feed
infantsi
import
maxim
reduct
diarrheal
diseas
transmiss
risk
handwash
key
person
includ
care
prepar
serv
food
infant
prepar
serv
food
vocat
eg
street
vendor
target
promot
campaign
increas
incid
diarrheal
diseas
concurr
introduct
wean
food
recogn
time
protect
effect
exclus
breastfeed
demonstr
repeatedli
addit
water
infus
type
milk
solid
food
infant
diet
cessat
breastfeed
associ
independ
greatli
increas
risk
develop
diarrhea
exclus
breastfeed
promot
exist
primari
healthcar
servic
mani
line
evid
suggest
wean
food
vehicl
enter
infect
numer
studi
demonstr
presenc
bacteri
enteropathogen
wean
food
dose
suffici
caus
ill
moreov
food
reduc
gastric
acid
predispos
one
develop
infect
even
lower
bacteri
inocula
requir
waterborn
persontoperson
transmiss
proper
food
prepar
handl
essenti
reduc
diarrheal
diseas
risk
infecti
human
anim
wast
contamin
water
use
fertil
irrig
fruit
veget
especi
grown
close
soil
eaten
raw
eg
lettuc
shellfish
harvest
contamin
water
seafood
product
anim
origin
never
eaten
raw
milk
boil
pasteur
thorough
cook
elimin
pathogen
food
howev
poor
hygien
improp
storag
lead
recontamin
multipl
bacteria
result
thoroughli
reheat
cook
food
serv
import
limit
data
avail
suggest
rate
diarrheal
ill
among
children
develop
countri
receiv
supplement
zinc
percent
lower
receiv
supplement
random
trial
demonstr
vitamin
supplement
reduc
incid
durat
diarrheal
ill
particularli
among
children
measl
vitamin
defici
contrast
trial
fail
identifi
signific
chang
incid
diarrheal
diseas
associ
vitamin
prophylaxi
find
suggest
vitamin
megados
actual
may
increas
risk
develop
diarrheal
ill
particularli
younger
children
month
addit
recent
review
nine
trial
found
consist
evid
back
use
vitamin
supplement
primari
prevent
diarrhea
howev
random
trial
conduct
among
bangladeshi
children
found
combin
effect
zinc
vitamin
supplement
diarrheal
incid
preval
superior
associ
either
macronutri
alon
moreov
find
literatur
highlight
effect
micronutri
supplement
reduc
incid
diarrheal
diseas
depend
larg
overal
immunolog
nutrit
state
child
research
need
assess
overal
util
supplement
micronutri
identifi
group
target
intervent
determin
optim
strategi
deliveri
typhi
two
typhoid
vaccin
current
approv
clinic
use
vi
capsular
polysaccharid
vaccin
approv
children
older
year
age
singl
parenter
dose
provid
high
level
protect
may
provid
protect
long
year
live
attenu
vaccin
similarli
efficaci
period
least
year
vaccin
administ
four
total
dose
given
everi
day
year
complet
seri
repeat
approv
children
year
older
typhoid
major
problem
among
children
develop
countri
unfortun
avail
vaccin
provid
conveni
requir
distribut
children
area
greatest
need
develop
vaccin
shigella
continu
high
public
health
prioriti
low
infecti
dose
high
incid
postinfecti
sequela
includ
proteinlos
enteropathi
malnutrit
antibodi
shigella
antigen
known
protect
robbin
cowork
produc
parenter
conjug
vaccin
consist
purifi
shigella
lipopolysaccharid
lp
conjug
protein
carrier
despit
exist
shigella
serotyp
certain
type
repres
disproportion
three
conjug
vaccin
candid
evalu
human
dysenteria
lp
conjug
tetanu
toxoid
flexneri
lp
conjug
recombin
pseudomona
exoprotein
sonnei
lp
conjug
exoprotein
three
vaccin
prove
immunogen
protect
shigellosi
field
trial
among
isra
soldier
parenter
shigella
vaccin
may
use
travel
militari
impract
use
develop
countri
promis
vaccin
formul
singledos
liveattenu
shigella
vaccin
would
induc
mild
immun
form
diseas
vaccin
develop
sever
laboratori
sansonetti
cowork
construct
seri
shigella
vaccin
candid
mutat
icsa
virg
gene
involv
spread
shigella
intestin
epithelium
also
construct
flexneri
vaccin
mutat
virg
ironscaveng
locu
iuc
clinic
trial
ingest
cfu
strain
caus
symptom
mild
shigellosi
volunt
wherea
dose
caus
mild
symptom
volunt
subsequ
challeng
studi
volunt
ingest
singl
dose
cfu
protect
challeng
wild
type
flexneri
noriega
cowork
kotloff
k
person
commun
similar
success
flexneri
strain
harbor
mutat
metabol
locu
guaba
put
enterotoxin
loci
set
sen
strain
design
cvd
well
toler
dose
cfu
provid
strong
serum
intestin
antibodi
respons
wherea
virg
mutat
alon
suffici
attenu
flexneri
virg
mutant
sonnei
design
mildli
reactogen
phase
clinic
trial
singl
dose
cfu
caus
lowgrad
fever
mild
diarrhea
percent
recipi
provid
strong
serum
intestin
antibodi
respons
v
cholera
two
oral
cholera
vaccin
one
liveattenu
one
inactiv
licens
industri
countri
cvd
ctxa
hli
classic
inaba
strain
first
recombin
liveattenu
cholera
vaccin
prove
welltoler
immunogen
protect
vaccin
current
licens
human
use
cvd
deriv
v
cholera
classic
inaba
strain
show
mild
defect
abil
colon
mous
human
intestin
addit
delet
catalyt
subunit
cholera
toxin
cvd
also
harbor
mutat
put
virul
factor
hli
express
classic
biotyp
strain
cvd
administ
individu
seri
placebocontrol
phase
phase
trial
random
doubleblind
placebocontrol
multicent
trial
singl
dose
strain
confer
percent
protect
efficaci
moder
sever
diarrhea
challeng
toxigen
el
tor
v
cholera
vaccin
shown
efficaci
field
studi
develop
countri
like
benefici
travel
endem
region
sever
nonmotil
deriv
v
cholera
evalu
potenti
vaccin
promis
candid
deriv
delet
cholera
toxin
genet
element
introduc
gene
encod
cholera
toxin
b
subunit
reca
locu
screen
nonmotil
v
cholera
el
tor
inaba
strain
show
percent
efficaci
homolog
challeng
cohort
adult
volunt
oral
cholera
vaccin
consist
nontox
highli
immunogen
cholera
toxin
b
subunit
protein
combin
heatand
formalinkil
v
cholera
classic
el
tor
vibrio
develop
sweden
b
subunitwhol
cell
bwc
vaccin
prove
safe
protect
cholera
lesser
extent
diarrhea
caus
etec
produc
cholera
toxinlik
heatlabil
enterotoxin
phase
phase
clinic
studi
establish
bwc
vaccin
caus
detect
side
effect
stimul
gut
mucos
iga
antitox
antibacteri
immun
respons
multipl
dose
durat
protect
vaccin
howev
like
shortliv
larg
field
trial
efficaci
estim
approxim
percent
year
still
higher
ca
longerterm
protect
efficaci
seen
older
age
year
vaccin
kill
vaccin
offer
promis
develop
countri
particularli
produc
local
etec
extrem
common
caus
infant
diarrhea
develop
world
vaccin
infect
must
safe
effect
young
infant
antibodi
colon
factor
antigen
thought
protect
etec
infect
yet
tremend
antigen
divers
present
daunt
obstacl
advanc
etec
vaccin
candid
compris
kill
whole
cell
formul
plu
recombin
cholera
toxin
b
subunit
vaccin
contain
five
strain
formalinkil
etec
collect
express
preval
fimbrial
antigen
colon
factor
antigeni
vaccin
safe
immunogen
adult
volunt
well
children
year
age
immun
respons
measur
intestin
lavag
antibodysecret
cell
elicit
cholera
toxin
b
subunit
well
fimbrial
type
addit
vaccin
immunogen
test
endem
area
adult
children
bangladesh
egypt
vaccin
current
avail
protect
shiga
toxinproduc
e
coli
infect
vaccin
candid
develop
includ
shiga
toxoid
polysaccharidebas
vaccin
live
attenu
construct
candid
vaccin
livestock
vaccin
also
undergo
develop
effort
develop
rotaviru
vaccin
pursu
improv
hygien
sanit
appear
reduc
diseas
incid
rate
similar
less
develop
industri
countri
initi
develop
rotaviru
vaccin
base
jennerian
approach
involv
use
liveattenu
antigen
relat
viru
deriv
nonhuman
host
bovin
rhesu
strain
later
observ
vaccin
challeng
crossprotect
studi
anim
suggest
serotypespecif
immun
may
import
protect
vaccin
develop
use
modifi
jennerian
approach
animalhuman
reassort
express
protein
differ
serotyp
use
immunogen
recent
liveattenut
vaccin
base
rotaviru
strain
deriv
young
children
neonat
develop
rotaviru
vaccin
licens
unit
state
recommend
routin
immun
infant
vaccin
tetraval
rhesushuman
reassort
rotaviru
tetraval
vaccin
rrvtv
develop
target
four
common
g
serotyp
rotaviru
howev
rrvtv
withdrawn
link
causal
intussuscept
estim
rate
case
per
vaccin
infant
manufactur
stop
product
rotaviru
vaccin
develop
two
vaccin
candid
pentaval
bovin
rotavirushuman
rotaviru
reassort
vaccin
merck
co
research
laboratori
west
point
pa
monoval
human
rotaviru
vaccin
glaxo
smithklin
philadelphia
pa
current
largescal
clinic
efficaci
trial
preliminari
trial
result
shown
vaccin
efficaci
evalu
safeti
use
children
ongo
key
question
remain
unansw
date
whether
merck
multival
rotaviru
vaccin
theoret
provid
better
protect
multipl
rotaviru
strain
offer
signific
clinic
benefit
compar
glaxo
smithklin
monoval
vaccin
trial
data
address
question
await
keenli
theoret
monoval
vaccin
could
produc
simpler
technolog
lower
price
therefor
less
expens
wide
avail
use
global
immun
program
past
sever
decad
rate
diarrheal
mortal
among
children
develop
countri
declin
significantli
howev
challeng
prevent
estim
million
death
caus
diarrhea
annual
persist
reduct
rate
mortal
diarrhea
requir
adopt
best
practic
guidelin
manag
children
diarrhea
appropri
use
prevent
strategi
efficaci
ort
reduc
sever
diarrhea
establish
unequivoc
global
or
coverag
rate
remain
less
percent
effort
must
made
improv
coverag
although
encourag
progress
made
reduc
rate
mortal
diarrhea
potenti
futur
reduct
clearli
evid
effort
protect
children
acquir
diarrheal
diseas
less
success
wide
rang
prevent
measur
relat
environment
host
factor
develop
refin
implement
yet
signific
impact
global
incid
diarrheal
diseas
elus
matter
call
work
field
whether
develop
vaccin
promot
micronutri
supplement
breastfeed
novel
approach
water
sanit
hygien
redoubl
effort
govern
financi
interest
support
endeavor
redoubl
commit
